Advertisement
News
Advertisement

Histogenics reports positive two-year NeoCart data

Fri, 06/08/2012 - 12:32pm
Mass High Tech: The Journal of New England Technology

Regenerative medicine company Histogenics Corp. of Waltham reported in a journal that its NeoCart tissue implant has shown greater clinical efficacy two years after treatment than microfracture surgery, which is the current standard of care.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading